These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8225679)

  • 1. Cutaneous and ocular changes associated with the use of chlorpromazine.
    Wolf ME; Richer S; Berk MA; Mosnaim AD
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
    [No Abstract]   [Full Text] [Related]  

  • 3. Chlorpromazine-induced skin pigmentation with corneal and lens opacities.
    Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM
    Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular complications of phenothiazines.
    Mathalone MB
    Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613
    [No Abstract]   [Full Text] [Related]  

  • 5. Relation of graded ocular anterior chamber pigmentation to phenothiazine intake in schizophrenics--quantification procedures.
    Thaler JS; Curinga R; Kiracofe G
    Am J Optom Physiol Opt; 1985 Sep; 62(9):600-4. PubMed ID: 4050962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ophthalmologic manifestations, with or without associated skin disorders, during prolonged treatment with chlorpromazine].
    Baron JB; Morel P; Rivoallan Y; Soulairac A
    Agressologie; 1968; 9(2):293-304. PubMed ID: 5675496
    [No Abstract]   [Full Text] [Related]  

  • 7. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ocular and cutaneous changes in patients exposed to prolonged treatment with neuroleptic drugs].
    Francesconi G; Di Tizio A; Cameo D
    Ann Ottalmol Clin Ocul; 1968 Jul; 94(7):835-52. PubMed ID: 4236709
    [No Abstract]   [Full Text] [Related]  

  • 9. Ocular effects of phenothiazine derivatives and reversibility.
    Mathalone MB
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561
    [No Abstract]   [Full Text] [Related]  

  • 10. Asymmetric anterior segment changes induced by chlorpromazine.
    Deluise VP; Flynn JT
    Ann Ophthalmol; 1981 Aug; 13(8):953-5. PubMed ID: 7294636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthetic antimalarials and skin].
    Ribrioux A
    Ann Dermatol Venereol; 1990; 117(12):975-90. PubMed ID: 2150584
    [No Abstract]   [Full Text] [Related]  

  • 12. An electron microscopic study of chlorpromazine pigmentation.
    Hashimoto K; Wiener W; Albert J; Nelson RG
    J Invest Dermatol; 1966 Oct; 47(4):296-306. PubMed ID: 5954160
    [No Abstract]   [Full Text] [Related]  

  • 13. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472
    [No Abstract]   [Full Text] [Related]  

  • 14. Ocular complications related to phenothiazines.
    Siddall JR
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:10-3. PubMed ID: 4876740
    [No Abstract]   [Full Text] [Related]  

  • 15. Unusual complications of antipsychotic drugs.
    Diamond JM; Santos AB
    Am Fam Physician; 1982 Oct; 26(4):153-7. PubMed ID: 6127024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 159(1):31-8. PubMed ID: 4984273
    [No Abstract]   [Full Text] [Related]  

  • 17. [Persistence of bilateral pigmentary deposits in stromal cornea in a woman after a brief treatment with antidepressants].
    Panzitt M; Simon M; Weger M
    Klin Monbl Augenheilkd; 2001 Apr; 218(4):273-5. PubMed ID: 11392274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blue skin pigmentation and chlorpromazine.
    Haddad RI
    J Ky Med Assoc; 1977 Mar; 75(3):124-6. PubMed ID: 839129
    [No Abstract]   [Full Text] [Related]  

  • 19. The prevalence of the ocular side effects of chlorpromazine in the Tuscaloosa Veterans Administration patient population.
    Alexander LJ; Bowerman L; Thompson LR
    J Am Optom Assoc; 1985 Nov; 56(11):872-6. PubMed ID: 4078212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ophthalmologic study of patients receiving psychotropic drugs].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.